Clinical Trial Update: Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating all-trans retinoic acid with induction and consolidation therapy plus pegfilgrastim in younger patients with newly diagnosed acute my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: University of Ulm | Conditions: Acute Myeloid Leukemia | Phase 2, Phase 3 | Status: COMPLETED